Skip to content

Clinical trial to study the efficacy of dadimadi avaleha in aruchi (Poor appetite) in children of age group 2 to 18 years

Randomized open controlled clinical study to evaluate the efficacy of dadimadi avaleha in aruchi with special reference to poor appetite in children of age group 2 tO 18 yrs . - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093061
Enrollment
80
Registered
2025-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

Dr Neha Vilas Randive
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients having reduced food intake. 2.patient having aruchi not more than one month.

Exclusion criteria

Exclusion criteria: 1.Patients known case of severe anemia, jaundice any underline infection. 2. Poor appetite more than 1 month. 3. Patients with malnutrition. 4. Patients with k/c/o genetic disease in born error of metabolism. 5. Children are below 2 years and above 18 years.

Design outcomes

Primary

MeasureTime frame
Dadimadi Avleha is significantly effective in management of Aruchi with special refrence to poor appetite in childrens of age 2 to 18 years.Timepoint: 30 days.

Secondary

MeasureTime frame
Dadimadi Avleha is not significantly effective in management of Aruchi with special refrence to poor appetite in childrens of age 2 to 18 years.Timepoint: 30 days.;Timepoint: ;To study the effects of ayurvedic dadimadi avlehaTimepoint: 30 days with follow up on 0 ,15,30 days

Countries

India

Contacts

Public ContactDr Neha Vilas Randive

LRP Ayurvedic medical college and hospital ,PG Institute and Research center ,urun islampur

sandeep.patil76.sp@gmail.com9860970379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026